LUCICRIZ 250mg (Crizotinib)

Description

LUCICRIZ 250mg (Crizotinib) is a targeted cancer medicine used to treat certain cancers that contain ALK or ROS1 gene mutations. Doctors commonly prescribe LUCICRIZ 250mg for ALK-positive or ROS1-positive metastatic non-small cell lung cancer (NSCLC) and some rare tumors such as ALK-positive inflammatory myofibroblastic tumors (IMT).

Dosage:
The usual adult dose of LUCICRIZ 250mg (Crizotinib) is 250 mg taken twice daily, with or without food, as directed by a healthcare professional. Treatment typically continues until disease progression or unacceptable side effects occur.

Side Effects

Some patients using LUCICRIZ 250mg (Crizotinib) may experience:

• Nausea
• Vomiting
• Diarrhea or constipation
• Fatigue
• Vision disturbances
• Loss of appetite

In rare cases, LUCICRIZ 250mg may cause serious side effects such as liver problems, heart rhythm changes, or lung complications. Patients should consult a doctor if severe symptoms occur.

Prescribing Information

Before starting treatment, doctors usually confirm the ALK or ROS1 gene mutation through diagnostic testing. LUCICRIZ 250mg (Crizotinib) should only be used under the supervision of an experienced healthcare professional.

Patients should inform their doctor about other medications and avoid using LUCICRIZ 250mg during pregnancy or breastfeeding.

Suggestion

For best results, take LUCICRIZ 250mg (Crizotinib) exactly as prescribed. Do not change the dose or stop treatment without medical advice. Regular monitoring during treatment is recommended.

FAQ

What is LUCICRIZ 250mg (Crizotinib) used for?
It is used to treat ALK-positive or ROS1-positive non-small cell lung cancer and certain rare tumors.

How does LUCICRIZ 250mg work?
LUCICRIZ 250mg (Crizotinib) blocks abnormal proteins such as ALK and ROS1, helping slow the growth of cancer cells.

How should LUCICRIZ 250mg be taken?
It is usually taken twice daily with or without food, as prescribed by a doctor.